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Abstract A method for the determination of a wide range
residues of anti-inflammatory drugs (16 acidic non-steroidal
anti-inflammatory drugs and four metamizole metabolites and
five corticosteroids) has been was developed. In the first step
of sample preparation, acetate buffer was added to minced
muscle samples and 15-min ultrasound-assisted enzymatic
hydrolysis was performed. Next, the samples were extracted
twice with acetonitrile, freezed and analysed. The analytes
were separated on a C18 column with a 25-min gradient of
methanol/acetonitrile (8:2) and 0.05 M ammonium formate at
pH 5.0 and determined by liquid chromatography-tandem
mass spectrometry (LC-MS/MS). The method was validated
according to the requirements described in the Commission
Decision 2002/657/EC: linearity, precision (repeatability and
within-laboratory reproducibility), accuracy, decision limit
CCα and detection capability CCβ were calculated. The
method developed fulfilled the performance criteria and can
be used in the official control of veterinary drug residues in
food of animal origin. The method was positively verified in
the proficiency test and in the analysis of incurred material.
Keywords Non-steroidal anti-inflammatory drugs .
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Introduction
Non-steroidal anti-inflammatory drugs (NSAIDs) and
glucocorticosteroids (GCs) are widely used in veterinary medi-
cine as well as in treatment of diseases in food-producing ani-
mals. Despite its effectiveness, the important drawback of phar-
macotherapy is drug residues in animal tissues. It became an
important issue in the food safety. Potential toxicity of medicinal
veterinary products has to be evaluated before the drug registra-
tion. When necessary, maximum residue limits (MRLs) in food
are established. In the case of NSAIDs, MRL values were
established in animal muscle for the following: salicylic acid
(400 μg kg−1 for turkey), flunixin (10 μg kg−1 for Equidae,
20 μg kg−1 for bovine, 50 μg kg−1 for porcine), meloxicam
(20 μg kg−1 for bovine, caprine, porcine, rabbit, Equidae),
metamizole (marker residue: 4-methylaminoantipyrine,
100 μg kg−1 for bovine, porcine, Equidae), diclofenac
(5 μg kg−1 for bovine, porcine), tolfenamic acid (50 μg kg−1
for bovine, porcine), carprofen (500 μg kg−1 for bovine,
Equidae) and firocoxib (10 μg kg−1, Equidae). For GCs, MRLs
for muscles are the following: dexamethasone (0.75 μg kg−1 for
bovine, caprine, porcine, Equidae), betamethasone
(0.75 μg kg−1 for bovine, porcine), methylprednisolone
(10 μg kg−1 for bovine, Equidae) and prednisolone (4 μg kg−1
for bovine, Equidae) (European Commission 2010). For some
other compounds (phenylbutazone, oxyphenbutazone, ibupro-
fen, naproxen, mefenamic acid), recommended concentration (5
or 10μg kg−1 for all species) has been proposed (CRLGuidance
Paper 2007). Important features of AI metabolism (like forma-
tion of glucuronides) impose the necessity of the application of a
hydrolysis step in the sample preparation (Jedziniak et al.
2013a). In some cases, a deconjugation step is necessary, e.g.
carprofen, when the marker residue was expressed as a Bsum of
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carprofen and carprofen glucuronide conjugate^ (European
Commission 2010).
In the case of glucocorticosteroids, a significant part of
residues are conjugated as glucuronide (e.g. 50 % of dexa-
methasone residues) (Vree et al. 1999). Some medicines like
phenylbutazone and diclofenac have limited stability in sam-
ples and during the sample preparation (Reddersen and
Heberer 2003; European Food Safety Authority 2013).
Residues of anti-inflammatory drugs (AIs), both NSAIDs
and GCs, have been found in food in recent years in relatively
low percentage. In the years 2007–2010, the proportion of
non-compliant samples in the European Union remained rel-
atively constant (around 0.1–0.2 %) (European Food Safety
Authority 2012). Nevertheless, the detection of phenylbuta-
zone residues (NSAIDwhich is not authorised for use in food-
producing animals), found in the horse meat, was an important
issue in the EU in 2012 (European Food Safety Authority
2013). In the group of GCs, dexamethasone was most com-
monly detected in bovines (21 non-compliant samples in
2009, representing 0.37 % of total samples) (European Food
Safety Authority 2011).
For the wider view on chemical contaminants in food,
dozens or even hundreds of analytes were included in
multiclass methods based on LC-MS/MS. Due to the variety
of chemical properties, only simple sample preparation can be
used, which is effective in the terms of analyte coverage but
can generate some difficulties. One of them is the matrix ef-
fect, phenomena (ion suppression or ion enhancement) caused
by matrix constituents present in the sample (Matuszewski
2006).
Most of the published LC-MS/MS methods cover a wide
range of NSAIDs or GCs. Recently, thanks to more sensitive
and faster mass spectrometers, AIs have been included in the
multiclass-multiresidue methods with LC-MS/MS (Geis-
Asteggiante et al. 2012; Robert et al. 2013) or LC-TOF (Ortelli
et al. 2009; Peters et al. 2009). Multiclass methods cover dozen
of analytes, but their sample preparation has to be very generic;
suchmethods cannot cover the analysis of conjugated analytes.
It should be emphasised that only few methods allow to
determine both groups of analytes and include hydrolysis of
phase II metabolites (e.g. glucuronides) in the sample
preparation.
Chrusch et al. published the procedure for the simultaneous
determination of 29 veterinary drugs (NSAIDs, GCs and an-
abolic steroids) in animal tissues based on acidic hydrolysis,
multistage solid-phase extraction (SPE) clean-up and different
LC conditions for specific groups of analytes (Chrusch et al.
2008). Recently, basic hydrolysis and clean-up with mixed-
mode cation-exchange cartridge were used for the simulta-
neous determination of corticosteroids, anabolic steroids and
basic NSAIDs in milk and muscles (Kaufmann et al. 2014).
An important drawback of the above methods is multistep
sample preparation based on the SPE.
The authors want to share their experience in the determi-
nation of NSAIDs in animal tissues ( Jedziniak et al. 2010,
Jedziniak et al. 2013b, Olejnik et al. 2013) and develop a new
method with wider range of analytes (both metamizole metab-
olites and Bacidic^ NSAIDs and GC), enzymatic hydrolysis
step and simple sample preparation. According to the best
authors’ knowledge, methods for the simultaneous determina-
tion of NSAIDs and GCs with enzymatic hydrolysis were not
published.
Such approach ensures faster and cheaper analysis and al-
lows to determine conjugated analytes, what is not possible
with previously published procedures.
Material and Methods
Reagents and Sorbents
Acetonitrile (ACN) and methanol (MeOH), both LC-MS
grade, were obtained from J.T. Baker, Germany. Ammonium
formate, HPLC grade, was from LGC Standard, UK. Sodium
acetate, puriss p.a. was purchased from POCH, Poland. Acetic
acid, formic acid (all LC-MS grade), β-glucuronidase from
Helix pomatia (HP-2) and ascorbic acid (puriss p.a.) were from
Sigma-Aldrich, Germany. Ultrapure water (resistance >18mΩ)
was obtained from Milli-Q system (Millipore, France).
The analytical standards were supplied by the following man-
ufacturers: diclofenac (DC), flunixin meglumine (FLU),
carprofen (CPF), mefenamic acid (MEF), tolfenamic acid
(TOL), meloxicam sodium (MEL), naproxen (NAP), celecoxib
(CELE), flufenamic acid (FLUF), ibuprofen (IBU), ibuprofen
glucuronide (IBU-GLU), dexamethasone (DEX),
betamethasone (BMT), flumethasone (FLUM), prednisolone
(PRED), carprofen-d3 (CPF-d3), meloxicam-d3 (MEL-d3)—
Sigma-Aldrich, Germany; 4-methylaminoantipyrine (4-MAA),
4-formylaminoantipyrine (4-FAA), 4-aminoantipyrine (4-AA),
4-acetylaminoantipyrine (4-AcAA), phenylbutazone (PBZ) and
oxyphenbutazone monohydrate (OPB)—LGC Standard, UK;
flurbiprofen (FLURB), flurbiprofen-d3 (FLURB-d3), indometh-
acin (IND), indomethacin-d4 (IND-d4), methylprednisolone
(MPRED), dexamethasone-d4 (DEX-d4), ibuprofen-13C3
(IBU-13C3)—Cambridge Isotopes Laboratories, USA; and
firocoxib (FIRO), fircoxib-d6 (FIRO-d6), phenylbutazone-13C12
(PBZ-13C12), oxyphenbutazone-13C6 (OPB-13C6) flunixin-d3
(FLU-d3) and 4-methylaminofenazone-d3 (4-MAA-d3)—
Witega, Germany. Niflumic acid (NIF), diclofenac-13C6 (DC-
13C6), mefenamic acid-d4 (MEF-d4) and tolfenamic acid-13C6
(TOL-13C6) were gifted by the EuropeanUnion Reference Lab-
oratory for Drug Residues in Berlin.
Cartridges and sorbents used for method development were
the following: C18 (500 mg, 3 mL, Avantor, USA); C18 bulk
sorbent (Avantor, USA); C8 (500 mg, 3 mL, Avantor, USA);
Oasis HLB (60mg, 3mL,Waters, USA); Strata X, Strata X-C,
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Strata XL and Strata XL-A (all 60 mg, 3 mL, Phenomenex,
USA); HybridSPE (100 mg, 3 mL, Supelco, USA); and pri-
mary secondary amine (PSA, Supelco, USA).
Standard Solutions, Buffers and Samples
Stock standard solutions (1000 μg mL−1) were prepared by
weighing of 10.0 mg of each analyte and dissolving in
10.0 mL of methanol (stable for 12 months). Working standard
solutions (100 μg mL−1) were prepared by the dilution of the
proper solutions with methanol and were stable for 6 months.
Three mixed standard solutions were prepared by the dilu-
tion of suitable aliquots of working standard solutions
(100 μg mL−1) and used for a muscle sample spiked on three
levels (Table 2). The first one contained 0.25 μg mL−1 of PBZ
and OPB and was stable for 1 month. The second one
contained 0.25 μg mL−1 of DC; 2.5 μg mL−1 of TOL;
1 μg mL−1 of MEL; 0.2 μg mL−1 of PRED; 0.0375 μg mL−1
of DEX; BMT; 5 μg mL−1 of 4-MAA; and 0.5 μg mL−1 of
FLU, MEF, NAP, IBU, FIRO, CELE, FLUF, FLURB, IND,
NIF, FLUM, MPRED, TRIAM, 4-FAA, 4-AA and 4-AcAA
and was stable up to 6 months. The third standard (the mixed
solution of internal standards (ISs)) contained 2.0 μg mL−1 of
each IS (DEX-d4, DC-13C6, PBZ-13C12, FIRO-d6, FLURB-
d3, FLU-d3, IBU-d3, IND-d4, CPF-d3, MEF-d4, TOL-13C6,
MEL-d3, 4-MMA-d3, OXPBZ-13C6) and was stable for
6 months. All standards solutions were stored at 2–10 °C and
used for spiking muscle samples at three levels.
Acetate buffer used in the enzymatic hydrolysis was prepared
by dissolving sodium acetate (2.7 g) and ascorbic acid (0.17 g)
in water (100 mL). The pH was adjusted to 4.5 with acetic acid.
A blankmuscle samples (bovine, swine, horse) were collect-
ed from different regions of Poland by veterinary inspection.
Equipment
In the sample preparation, vortex mixer (IKA, Germany), nitro-
gen evaporator (VLM, Germany), freezer (Liebherr, Germany),
laboratory centrifuge (Sigma, Germany) and laboratory glass-
ware and pipettes were used. Syringe filters (Puradisc PTFE
0.45μm)were fromWhatman, UK. The analysiswas performed
usingAgilent 1200 liquid chromatograph (Agilent Technologies,
Germany) connected to ABSciex QTRAP 5500 mass spectrom-
eter (ABSciex, Canada), controlled by Analyst 1.5 software.
Sample Preparation
The muscle samples (2±0.01 g) were weighed into a 50-mL
polypropylene centrifuge tube. The volume 20μL of IS solution
was added, and the sample was vortex-mixed and allowed to
rest for 10 min. Then, acetate buffer (4 mL) and β-
glucuronidase (50 μL) were added. The sample was vigorously
mixed and sonicated (15 min, 37 °C). Next, the sample was
extracted with two portions of ACN (5 mL) by vortex mixing
(1 min) and centrifuged (4120×g, 20 min, −5 °C). The com-
bined extracts (10 mL) were transferred into a 10-mL glass tube
and placed in the freezer (−20 °C) for 60min. The upper layer of
the extract (2 mL) was collected and evaporated to dryness in
the nitrogen stream (at 40 °C) and reconstituted in 1 mL of
mobile phase (MeOH/ACN/H2O, 0.5:0.5:9, v/v/v). The sample
was filtered through syringe filters, transferred into the
autosampler vial and analysed by LC-MS/MS.
LC-MS/MS Analysis
The chromatographic separation was carried out on a Luna
C18 column (3 μm, 4.6×150 mm, Phenomenex, USA) con-
nected with a C18 guard column (2.0×4 mm, Phenomenex,
USA). The gradient was applied withMeOH/ACN (8+2, v+v,
containing 0.1 % formic acid—phase A) and 0.01 M ammo-
nium formate, pH 5.0 (phase B). The initial conditions of the
gradient kept until 5 min were 15 % A and 85 % B. The phase
A content was increased to 32 % at 5.5 min, and such condi-
tions were maintained until 12 min. Next, phase A content
was increased to 48 % at 12.5 min. From 12.5 to 16 min, the
content of phase Awas increased to 70%, and such conditions
were maintained until 20 min. From 20.5 min, the system was
re-equilibrated with the initial composition of the mobile
phase. The total run time of the method was 24 min. The flow
rate was 0.8 mL min−1, the injection volume was 50 μL, and
the column temperature was 30 °C.
Mass spectrometry analysis was performed using
electrospray (electrospray ionization (ESI), polarity switching)
in multiple reaction monitoring (MRM) mode. The ESI inter-
face conditions were optimised as follows: the source temper-
ature 600 °C, capillary voltage −4.5 kV in negative mode and
+5.5 kV in positive mode, curtain gas 30 psi, nebuliser gas
60 psi and turbo heater gas 20 psi. For each analyte, two
fragmentation reactions were monitored whereas one was
monitored for ISs. Detailed MS conditions are described in
Table 1.
Verification of Enzymatic Hydrolysis Efficiency
The blankmuscle samples (bovine, swine, horse muscle, n=3)
were spiked with IBU-GLU standard at the level of 50 μg/kg.
The samples were determined with a developed procedure,
and IBU concentration was measured.
Development of Extract Clean-Up (SPE, Dispersive SPE,
Freezing)
The extracts (n=3) of spiked samples were passed through
SPE cartridges (C18, C8, HLB, Strata X, Strata X-C,
Hybrid) and eluate was collected. The cartridges were vacuum
dried for 1 min, and eluate was evaporated to dryness (N2,
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40 °C). The dry residue was reconstituted in 1 mL of mobile
phase (MeOH/ACN/H2O, 0.5:0.5:9, v/v/v) and analysed by
LC-MS/MS. For verification of dispersive SPE, the following
sorbents: C18 (100 mg) and C18 with PSA (both 100 mg)
were added to 2 mL of extracts, vortex-mixed (1 min) and
centrifuged (14,000 rpm). The 1 mL of extract was evaporated
to dryness (N2, 40 °C), reconstituted in 1 mL of mobile phase
and analysed by LC-MS/MS.For verification of freezing ef-
fectives, the spiked extracts (10 mL) were and placed in the
freezer (−20 °C) for 60 min. The upper layer of the extract
(2 mL) was collected and evaporated to dryness in the nitro-
gen stream (at 40 °C) and reconstituted in 1 mL of mobile
phase and analysed by LC-MS/MS.
Validation
The method was validated as a confirmatory procedure
according to Commission Decision 2002/657/EC (Europe-
an Commission 2002), and all criteria for confirmation
(requirements for retention time and criteria for ion ratios)
were taken from the above document. Standard calibration
curves were prepared by the injection of mixed standard
solutions on five concentration levels and plotting ratios of
recorded peak areas of each analyte and adequate ISs ver-
sus concentration. In the selectivity study, 20 blank muscle
samples from animals (bovine, swine, horse) from different
regions of Poland were analysed. The matrix effect was
Table 1 MS/MS parameters for













4-Acetylaminoantipyrine 246 192 104, 83a 31, 42 4-MAA-d3
4-Aminoantipyrine 204 185 83, 56a 42, 19 4-MAA-d3
4-Formylaminoantipyrine 232 191 104, 83a 29, 27 4-MAA-d3
4-Methylaminoantipyrine 218 170 97, 56a 17, 44 4-MAA-d3
Celecoxib 382 290 362a, 282 40, 45 FIRO-d6
Diclofenac 296 50 250a, 215 17, 27 DC-13C6
Firocoxib 337 100 283a, 237 14, 23 FIRO-d6
ESI−
5-Hydroxyflunixin 311 −51 267, 227 −22, −33 FLU-d3
Betamethasone 437 −80 361, 307 −25, −40 DEX-d4
Carprofen 272 −40 228, 226a −17, −37 CPF-d3
Dexamethasone 437 −65 361a, 307 −25, −42 DEX-d4
Diclofenac 294 −80 250a, 214 −28, −16 DC-13C6
Flufenamic acid 280 −157 236a, 216 −24, −26 FLU-d3
Flumethasone 455 −75 379a, 325 −25, −31 DEX-d4
Flunixin 295 −51 251a, 191 −25, −41 FLU-d3
Flurbiprofen 243 −70 199a, 175 −10, −12 FLURB-d3
Ibuprofen 205 −20 161, 159 −9, −11 IBU-13C3
Ibuprofen glucuronide 381 −20 193,205 −8,-12 IBU-13C3
Indomethacin 356 −97 312a, 297 −12, −27 IND-d4
Mefenamic acid 240 −60 196a, 192 −24, −40, MEF-d4
Meloxicam 350 −55 286a, 146 −17, −25 MEL-d3
Methylprednisolone 419 −79 343a, 309 −25, −43 DEX-d4
Naproxen 229 −50 185a, 170 −14, −20 FLU-d3
Niflumic acid 281 −155 237a, 217 −23, −30 FLU-d3
Oxyphenbutazone 323 −56 295a, 134 −25, −35 OPB-13C6
Phenylbutazone 307 −70 279a, 131 −26, −28 PBZ-13C12
Prednisolone 405 −80 329a, 295a −23,−25 DEX-d4
329 −200
Tolfenamic acid 260 −74 227, 216a −14, −22 TOL-13C6
Triamcinolone acetonide 479 −70 413a, 337 −30, −20 DEX-d4
ESI+ positive ionization, ESI negative ionization)
a Transition used for quantification
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verified by the post-extraction addition method. Blank
muscle samples (bovine, swine, horse muscles, each of
n=6) were spiked with standard solution at the spiking
level II (Table 2) at the end of the analytical procedure (just
before final evaporation) and determined. The ratios of
analytes’ peak areas in the post-extraction samples and
injected working standard solutions were calculated and
expressed as Bpercents^ (relative matrix effect). The above
calculation was performed using correction for IS (IS-
corrected relative matrix effect).
In the accuracy and precision study, muscle samples
(previously determined as blank ones) were spiked with
AIs on three levels: 0.5, 1 and 1.5 times the MRL for 4-
MAA, FLU, MEL, TOL, DC, DEX, BET, PRED, CPF and
MPRED. For other compounds, spiking levels were chosen
by the authors considering the concentration proposed by
European Union Reference Laboratories (Table 2) or pro-
visional sensitivity of the method. For the repeatability
study, three series of swine muscle were analysed under
the identical conditions (six samples for each spiking lev-
el). Standard deviation (SD) and coefficient of variation
(CV, %) were calculated for each level. The within-
laboratory reproducibility was obtained by the analysis of
two additional series (on three levels) in reproducibility
conditions (another technician, two different days) of bo-
vine and horse muscles, and overall SD and CV were cal-
culated. The overall mean concentrations obtained in the
reproducibility study were used to calculate accuracy (%).
Decision limits (CCα) and detection capability (CCβ)
were calculated using within-laboratory reproducibility re-
sults, according to the procedure described in the Com-
mission Decision 2002/657/EC (European Commission
2002) and the guidance paper (CRL Guidance Paper
2007). CCα and CCβ were calculated according to the
following equation:
CCα ¼ MRL or 1st spiking levelð Þ þ 1:64 SDWLR
CCβ ¼ CCα þ 1:64 SDWLR
MRL or 1st spiking levelð Þ
– concentration equal to MRL value or 1st spiking level
SDWLR– standard deviation of within
−laboratory reproducibility at MRL=1st spiking level
Limit of quantitation was established as the lowest point of
matrix calibration curve. The uncertainty (U) was calculated
as the ratio of coverage factor (k=2) and standard deviation
(SD) of within-laboratory reproducibility:
U ¼ k*SDwithin−laboratory reproducibility
and expressed in percent.
Methods’ Comparison
The incurred material (muscle samples: pork chop, pork neck,
pork shoulder) was collected from pig euthanised 24 h after
administration of Dexafort™ (DEX, dose 0.6 mg kg1, b.w.,
I.V.) The experiment was carried out in compliance with the
Decision No 2/2012 of the Local Animal Experimentation
Ethics Committee in Lublin, Poland.
The collected muscle samples (pork chop, pork neck, pork
shoulder, each of n=3) were analysed with the described pro-
cedure. The muscle samples were also analysed according to
the procedure for determination of corticosteroids (Van den
Hauwe et al. 2002).
Results and Discussion
LC-MS/MS Conditions
During the development of the method, we used our previous
experiences with the determination of NSAIDs in milk, where
negative ionisation was more suitable for most of acidic
NSAIDs and positive ionisaton showed better signal to noise
values for metamizole metabolites, coxibs and some NSAIDs
like DC (Jedziniak et al. 2012). GCs also can be detected in
both polarities, but we decided to determine stable negatively
ionised formic adducts of the analytes [M+formate]− accord-
ing to the method published by Van de Hauwe et al. (2002).
Although formic acid seems to be a proper choice as an addi-
tive in mobile phase for acidic analytes, it was not suitable in
the case of metamizole metabolites (wide and tailing peaks).
Thus, a composition of the mobile phase (MeOH/ACN and
0.05 M ammonium formate solution at pH 5.0) was a com-
promise between peak shape, sensitivity and time of analysis.
The separation of DEX and BMT (two isomers with the
sameMRM transitions) was an additional challenge. In recent
publications, two strategies were observed: first, separation
with carbon-loaded column (Li et al. 2010) or C18 column
with relatively long runtimes (Chen et al. 2010). Shorter sep-
aration time can be achieved with UHPLC systems (Herrero
et al. 2012; Tölgyesi et al. 2012; Deceuninck et al. 2013). Our
early experiences show that C18 or C8 columns (Intersil from
GLScience, Luna and Kinetex from Phenomenex, Halo from
Fig. 1 Ion chromatogram (transitions used for quantification) obtained
from bovine muscle sample spiked with anti-inflammatory drugs at level
II (4-AA 4-aminofenazone, 4-AcAA acetylaminofenazone, 4-FAA 4-
formylaminofenazone, 4-MAA 4-methylaminofenazone, PRED prednis-
olone, MEL meloxicam, MPRED methylprednisolone, BMT
betamethasone, DEX dexamethasone, FLUM flumethasone, NAP
naproxen, OPB oxyphenbutazone, FLU flunixin, NIF niflumic acid,
FIRO firocoxib, FLURB flurbiprofen, CPF carprofen, DC diclofenac,
IND indomethacin, PBZ phenylbutazone, FLUF flufenamic acid, IBU
ibuprofen,MEFmefenamic acid, TOL tolfenamic acid, CELE celecoxib)
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AMT) in classic MS format (150×2.1 mm, 3 μm) and differ-
ent gradient profiles separate both compounds insufficiently
with described mobile phase and gradient. For this reason, we
adopted wider column (150×4.6 mm, 3 μm) with higher flow
rate (0.8 mL min −1) according to the experience of Malone
et al. (2009) (Fig. 1).
Sample Preparation Development—Enzymatic
Hydrolysis
The inclusion of deconjugation step, i.e. enzymatic or chem-
ical hydrolysis, was an important assumption of the method.
Although some authors use acidic (Chrusch et al. 2008) or
alkaline hydrolysis (Chen et al. 2010; Kaufmann et al.
2014), in most published methods, enzymatic hydrolysis with
beta-glucuronidase was used (Jedziniak et al. 2010; Van den
Hauwe et al. 2002). An important advantage of using chemi-
cal hydrolysis is the effectiveness of the reaction, whereas
enzymatic hydrolysis is more selective and ensures milder
conditions than chemical one, what results in cleaner extracts
(Wang et al. 2011). Optimisation of this step of sample prep-
aration requires incurred material and was performed in some
previous studies (Van den Hauwe et al. 2002). For DEX
deconjugation step in liver samples, 4-h enzymatic hydrolysis
Fig. 2 Ion chromatogram obtained from swinemuscle samples spiked with ibuprofen glucuronide (IBU-GLU): a sample preparationwithout enzymatic
hydrolysis and b sample preparation with enzymatic hydrolysis
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at pH of 5.2 and at 40 °C was necessary. In our procedure, the
time of hydrolysis was shortened to 15 min at 37 °C using
ultrasonication (Alvarez-Sánchez et al. 2009). Verification of
hydrolysis efficiency was performed with the analysis of
blank samples spiked with IBU-GLU. As a result, IBU pres-
ence was confirmed and reduction of IBU-GLU peak area
(99 %) was observed (Fig. 2).
Sample Preparation Development
An important drawback of enzymatic hydrolysis is the in-
crease in matrix constituents that can interfere with analytes,
requiring a more effective clean-up (Wang et al. 2011). Al-
though SPE was widely used in the NSAID and GC analysis
(Antignac et al. 2001; Gentili et al. 2012), this kind of clean-up
(loading sample, cleaning solvent and elution) was not veri-
fied in this study due to longer time of sample preparation and
poor retention of metamizole metabolites on the reversed-
phase sorbents (Jedziniak et al. 2012). SPE cartridges (C18,
C8, Oasis HLB, Strata X, Strata X-C, Strata XL, Strata XL-A,
HybridSPE) were used only as the filter of ACN extract (the
extract was passed through the cartridge). Additionally, the
effectiveness of dispersive SPE with C18 and PSA sorbent
was evaluated. The results (Fig. 3) show relatively wide range
Fig. 3 Analytes’ extraction
recoveries using different sample
preparations (different sorbents
and freezing used as clean-up
step). Recovery rate was calculat-
ed without internal standard
correction
Fig. 4 Internal standard-corrected matrix effect in bovine, swine and horse muscle samples (mean and standard deviation)
Food Anal. Methods (2016) 9:1837–1848 1845
of analytes’ recoveries (extraction recoveries) for different
cartridge/sorbent combinations. This observation confirms
our experience that SPE or dSPE clean-up did not guarantee
high recoveries for most analytes. Moreover, we also observed
that a freezing step (1 h, −18 °C) gives comparable recoveries
to procedures with clean-up based on SPE or dispersive SPE
(Fig. 3). Due to the simplicity of the sample preparation and its
effectiveness, we decided to involve this step into the final
procedure.
Validation
During verification of the selectivity of the method, we did not
observed interference peaks in the retention time of analytes in
analysed muscle samples. Nowadays, calculation of a matrix
effect became the important part of validation in the method
based on LC-MS/MS technique. Although performance
criteria for this parameter were not established, many authors
present ion suppression (or rarely ion enhancement) of
developed methods. The results of the matrix effect study
are presented in Fig. 4.
The obtained results show significant reduction of all
analytes’ peak areas (ion suppression). The calculated relative
matrix effect was in the range of 28–77%. The use of isotope-
labelled ISs reduced the influence of this factor in quantita-
tion: IS-corrected relative matrix effect was in the range −29–
30 %% for all analytes with CV in the range 1–20 %.
The linearity of the method (correlation coefficient) and
range of the method were on the acceptable level. The valida-
tion results show high accuracy for most analytes, in the range
of 75–18 %. The lower accuracy was noticed for NIF (61–
67 %) and FLUF (36–46 %) and slightly higher AcAA (100–
124 %). The reason for this could be the lack of the proper
labelled IS. The results of repeatability (CV=3.2–19.6 %) and
within-laboratory reproducibility (CV=4.2–25.6 %) study
show acceptable precision of determination of most com-
pounds. Calculated CCα and CCβ values were slightly higher
for MRL compounds and lower than recommended concen-
trations for those NSAIDs which are non-registered for food
animals (Table 2). The results of validation suggest that, in the
routine analyses, the use of matrix-matched calibration curves
is preferable.
Method’s Verification
Muscle samples taken from pig (pork chop, pork neck, pork
shoulder) were analysed by the developed procedure with
ultrasonic-assisted enzymatic hydrolysis with beta-
glucuronidase (15 min, 37 °C), and the results were compared
with those obtained by analysing the muscle samples with
procedure making use of 4-h enzymatic hydrolysis at 40 °C
(Table 3). The results of analyses were comparable (t test,
P>0.05) and show efficiency of the developed procedure with
determination of AI residues in incurred material.
The developed procedure was successfully verified in the
FAPAS proficiency test (PBZ in equine muscle, nr 02231).
The calculated z-score for results (4.67 μg kg−1 of PBZ) was
in the range −2<z<2 (z-score=0.0).
Conclusions
The authors presented fast multiresidue method for the deter-
mination of AIs in animal muscles. It allows to determine a
wide range (25) of NSAIDs and GCs in muscles on the levels
required by the law and recommendation of European Union
Reference Laboratory. An important advantage of the devel-
oped method is short time of enzymatic hydrolysis step and a
simple sample clean-up. The results of method validation
show its applicability as a screening and confirmatory
procedure.
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Table 3 Results of the muscle sample analysis collected from the pigs treated with anti-inflammatory drugs
Medicine used Analyte Developed procedure
(μg kg−1, n=2, mean±SD)
Van den Hauwe et al. (2002)
(μg kg−1, n=2, mean±SD)
Pork chop Pork neck Pork shoulder Pork chop Pork neck Pork shoulder
Dexafort™ (dexamethasone,
dose 0.6 mg/kg, b.w., I.V.)
Dexamethasone 0.24±0.07 0.21±0.03 0.37±0.03 0.39±0.03 0.29±0.04 0.36±0.02
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All institutional and national guidelines for the care and use of labo-
ratory animals were followed. The animal study described in the paper
was carried out in compliance with the Decision No 2/2012 of the Local
Animal Experimentation Ethics Committee in Lublin, Poland.
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